Patents
Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
06/2013
06/05/2013CN103130780A Preparation method for chiral N-epoxypropyl phthalimide
06/05/2013CN103130779A Maleimides ionic liquid containing carbonic ester perssad and preparation method and application thereof
06/05/2013CN103130778A Pyrazines ionic liquid containing carbonic ester group and preparation method and application thereof
06/05/2013CN103130777A Pyridines ionic liquid containing carbonic ester group and preparation method and application thereof
06/05/2013CN103130776A Imidazoles ionic liquid containing carbonic ester perssad and preparation method and application thereof
06/05/2013CN103130775A Indolinone derivatives serving as tyrosine kinase inhibitors
06/05/2013CN103130766A Piperine hydrazone or acylhydrazone or sulfonyl hydrazone derivative substances and application for preparing a botanical insecticide
06/05/2013CN103130730A Novel quinazoline derivative, and preparation method, anti-HIV activity and anti-TMV activity thereof
06/05/2013CN103130722A Novel pyridazine derivative, and preparation method, anti-HIV activity and anti-TMV activity thereof
06/05/2013CN102304091B Emodin and fluorouracil combined compound having antitumor activity and preparation method thereof
06/05/2013CN102134234B Indazolyl urea compounds and preparation method and medicinal use thereof
06/05/2013CN101906096B 3,4-dihydropyridine-2-ketone heterocyclic compound and application thereof
06/05/2013CN101597280B Compound used as seven-pass transmembrane protein and based on sag structure
06/04/2013US8455665 3-phenoxymethylpyrrolidine compounds
06/04/2013US8455653 Hydroxy-6-heteroarylphenanthridines and their use as PDE4 inhibitors
06/04/2013US8455521 Diaminoalkane aspartic protease inhibitors
06/04/2013US8455498 Inhibitors of histone deacetylase
05/2013
05/30/2013WO2013078361A1 Solid state forms of vilazodone and vilazodone hydrochloride
05/30/2013WO2013078086A1 Photochromic compounds having at least two photochromic moieties
05/30/2013WO2013077362A1 Aromatic heterocyclic derivative, material for organic electroluminescent element, and organic electroluminescent element
05/30/2013WO2013077352A1 Aromatic heterocyclic derivative, material for organic electroluminescent element, and organic electroluminescent element
05/30/2013WO2013076090A1 3-phenyl-isoquinolin-1(2h)-one derivatives as parp-1 inhibitors
05/30/2013WO2013076063A1 Novel pyrrolidine derivatives as inhibitors of cathepsin
05/30/2013US20130137744 Pyrrolidine triple reuptake inhibitors
05/30/2013US20130137689 Novel acylpiperazinones and their use as pharmaceuticals
05/30/2013US20130137686 Benzene, pyridine, and pyridazine derivatives
05/30/2013US20130137679 Novel Functionally Selective Ligands of Dopamine D2 Receptors
05/30/2013US20130137675 Heterocyclic compound and use thereof
05/30/2013US20130137673 Inhibitors of jak
05/30/2013US20130137661 Gonadotropin Releasing Hormone Receptor Antagonist, Preparation Method Thereof And Pharmaceutical Composition Comprising The Same
05/30/2013US20130137660 Inhibitors of kinase activity
05/30/2013US20130137648 Derivatives of 1-phenyl-2-pyridinyl alkyl alcohols as phosphodiesterase inhibitors
05/30/2013US20130136794 Heteroaryl (alkyl) dithiocarbamate compounds, preparation methods and uses thereof
05/30/2013CA2856759A1 3-phenyl-isoquinolin-1(2h)-one derivatives as parp-1 inhibitors
05/30/2013CA2856306A1 Selective kinase inhibitors
05/30/2013CA2856301A1 Pyrazine kinase inhibitors
05/30/2013CA2854649A1 Solid state forms of vilazodone and vilazodone hydrochloride
05/30/2013CA2854569A1 Novel pyrrolidine derivatives as inhibitors of cathepsin
05/29/2013CN1747730B Pyrazole derivatives modulators of hepatocyte growth factor (scatter factor) activity
05/29/2013CN103121996A Novel heteroaryl-substituted arylaminopyridine derivatives as mek inhibitors
05/29/2013CN103121995A 3-alkyl-5- (4-alkyl-5-oxo-tetrahydrofutran-2-yl) pyrrolidin-2-one derivatives as intermediates in the synthesis of renin inhibitors
05/29/2013CN103121973A Pyrimidine urea derivatives as kinase inhibitors
05/29/2013CN103121972A Pyrimidine urea derivatives as kinase inhibitors
05/29/2013CN101370804B Aminophenyl derivatives as novel inhibitors of histone deacetylase
05/28/2013US8450486 6-alkenyl and 6-phenylalkyl substituted 2-quinolinones and 2-quinoxalinones as poly(ADP-ribose) polymerase inhibitors
05/28/2013US8450362 Amidine-containing compounds useful as muscarinic receptor antagonists
05/28/2013US8450341 Substituted indolin-2-one derivatives and their use as P38 mitogen-activated kinase inhibitors
05/28/2013US8450307 Therapeutic agents, and methods of making and using the same
05/28/2013US8450303 Azetidinyl diamides as monoacylglycerol lipase inhibitors
05/28/2013CA2735184C Heteroaryls amide derivatives and their use as glucokinase activators
05/28/2013CA2577467C Hiv inhibiting 5-heterocyclyl pyrimidines
05/28/2013CA2565630C Pyrrolidin-2-one and piperidin-2-one derivatives as 11-beta hydroxysteroid dehydrogenase inhibitors
05/28/2013CA2561897C Thio-substituted biaryl-methanesulfinyl derivatives
05/28/2013CA2561066C Antiviral 4-aminocarbonylamino-substituted imidazole compounds
05/28/2013CA2547887C Protein modifier production inhibitor
05/28/2013CA2539823C Hemiasterlin derivatives and uses thereof
05/28/2013CA2485346C Human adam-10 inhibitors
05/28/2013CA2455100C Mediators of hedgehog signaling pathways,compositions and uses related thereto
05/23/2013WO2013074459A1 Methods and compositions associated with the granulocyte colony-stimulating factor receptor
05/23/2013WO2013073577A1 Dihydroxy aromatic heterocyclic compound
05/23/2013WO2013072825A1 Phtalazinone derivatives as mpegs -1 inhibitors
05/23/2013WO2013049591A3 Dual inhibitor compounds and methods of use thereof
05/23/2013WO2013042138A3 Process for preparation of triazole antifungal drug, its intermediates and polymorphs thereof
05/23/2013US20130131351 Gpr120 receptor agonists and uses thereof
05/23/2013US20130131321 LIGANDS FOR ANTIBODY AND Fc-FUSION PROTEIN PURIFICATION BY AFFINITY CHROMATOGRAPHY
05/23/2013US20130131090 Salts of lapatinib
05/23/2013US20130131075 New compounds
05/23/2013US20130131062 Pyridazinones and furan-containing compounds
05/23/2013US20130131061 Novel Estrogen Receptor Ligands
05/23/2013US20130131056 Positive allosteric modulators (pam)
05/23/2013US20130131052 Amelioration Of The Development Of Cataracts And Other Ophthalmic Diseases
05/23/2013US20130131047 Pharmacokinetically improved compounds
05/23/2013US20130131040 Pyrazine kinase inhibitors
05/23/2013US20130131036 Novel trpv3 modulators
05/23/2013US20130131018 Substituted isoquinolines and their use as tubulin polymerization inhibitors
05/23/2013US20130129795 Inhibition and dispersion of bacterial biofilms with imidazole-triazole derivatives
05/22/2013EP2594565A2 2-acylaminopropanol-type glucosylceramide synthase inhibitors
05/22/2013EP2594564A2 2-acylaminopropanol-type glucosylceramide synthase inhibitors
05/22/2013EP2594563A2 2-acylaminopropanol-type glucosylceramide synthase inhibitors
05/22/2013EP2594562A2 2-acylaminopropanol-type glucosylceramide synthase inhibitors
05/22/2013EP2594559A1 Pyrazole compound
05/22/2013EP2594555A1 HETEROCYCLIC COMPOUND, AND p27 KIP1 DEGRADATION INHIBITOR
05/22/2013EP2593447A2 New heterocyclic compounds as pesticides
05/22/2013EP2593432A1 N-sulfonylbenzamide derivatives useful as voltage gated sodium channel inhibitors
05/22/2013CN1993339B Aromatic compounds
05/22/2013CN103119045A Pyrrolopyrimidine compounds and uses thereof
05/22/2013CN103119028A 1,2,4-Triazolone Derivative
05/22/2013CN103113358A Preparation method of 3, 3-bi (N-octyl-2-methylindole) phthalide
05/22/2013CN103113357A Preparation method of statin intermediate and derivatives thereof
05/22/2013CN103113356A Method for preparing rosuvastatin calcium intermediate
05/22/2013CN103113340A Genistein alkylamine compound, preparation method and use of genistein alkylamine compound
05/22/2013CN103113301A Thiourea huperzine A compound and preparation method of compound as well as application of compound in pesticides
05/22/2013CN102285945B Method for preparing alpha-carbonyl epoxy compound
05/22/2013CN102137844B Compounds and compositions as modulators of GPR119 activity
05/22/2013CN102134214B Isoindolone compounds and their use as metabotropic glutamate receptor potentiators
05/22/2013CN102108083B Polycyclic benzopyrone compounds and preparation method and application thereof
05/22/2013CN101835756B 1,4-disubstituted 3-cyano-pyridone derivatives and their use as positive MGLUR2 -receptor modulators
05/22/2013CN101687786B Hydroxylamine compounds and methods of their use
05/22/2013CN101479250B Tetrazole-substituted arylamides
05/21/2013US8445694 Hydrazonopyrazole derivatives and their use as therapeutics
1 ... 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 ... 694